[Polyomavirus and tubulointerstitial nephropathy].
Antoine
C
C
Service d'anatomo-pathologie, Hôpital Edouard-Herriot, Lyon. corinne.antoine@brs.ap-hop-paris.fr
Hill
G
G
Glotz
D
D
Fontanière
B
B
Tabone
E
E
Nochy
D
D
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001739:BK Virus / Q000254:growth & development / Q000302:isolation & purification*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D006084:Graft Rejection; D006801:Humans; D016867:Immunocompromised Host; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D009395:Nephritis, Interstitial / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology* / Q000473:pathology / Q000821:virology; D009894:Opportunistic Infections / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology / Q000821:virology; D027601:Polyomavirus Infections / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology; D011183:Postoperative Complications / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology / Q000821:virology; D012307:Risk Factors; D013601:T-Lymphocytes; D014775:Virus Activation
D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D000998:Antiviral Agents; D007166:Immunosuppressive Agents